Aegros
Deepa Kumar is a seasoned professional in the field of quality assurance and laboratory analysis, currently serving as a Quality Assurance Specialist at Aegros since December 2023. Prior experience includes roles as a Quality Assurance Analyst at GMP Pharmaceuticals Ltd from January 2018 to December 2023, and as a Laboratory Analyst at Lipa Pharmaceuticals Limited from March 2015 to January 2018. Additionally, Deepa held positions as a Technical Assistant at PepsiCo Australia and New Zealand, QA Chemist at Alphapharm, Industrial Chemist at Genesis Energy, Industrial Consultant at Quality Environmental Consulting Ltd, and Chemist at Punjas and Emperor Gold Mine. Deepa Kumar earned a Bachelor of Science degree in Chemistry from The University of Waikato between 1999 and 2002.
This person is not in the org chart
This person is not in any teams
Aegros
At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.